Following the strategy to broaden its nutritional focus, AAK has recently delivered its first volumes of Akovita, the company’s new product range for the senior nutrition market. AAK’s tailor-made speciality blend Akovita will be used in a powder product for the European market.

The Akovita range contains ingredients such as plant sterol esters which are clinically proven to maintain and even reduce the cholesterol level in the blood. This is supported by Article 14(1) health claim in the EU.

“To maintain an active lifestyle going into post-retirement, energy-dense and easily absorbed food with a good nutritional profile can support digestive health,” said Karel Stoschek, President Special Nutrition at AAK. “This can be achieved by incorporating AAK’s structured fats together with high amounts of the essential omega-3 fatty acids.”

AAK’s Special Nutrition segment, comprised of Infant, Medical and Senior Nutrition, was established at the end of last year in order to meet current and future demands on the various nutrition markets. AAK says it has strengthened resources for this new segment which is also an important focus area within The AAK Way, AAK’s company program for 2017–2019.

“AAK has, with its customer co-development approach, all the capabilities necessary for this wider nutrition platform,” said Stoschek. “We have strong knowledge and a solid reputation within speciality oils and fats, we have a global production footprint, and we have commercial and knowledgeable customer innovation teams to support our customers all over the world.”

AAK’s volumes of Akovita are expected to gradually increase over the coming years.